miriam martini
University of Turin
Turin, Italy
Review Editor
Pharmacology of Anti-Cancer Drugs
University of Turin
Turin, Italy
Review Editor
Pharmacology of Anti-Cancer Drugs
Institut Jules Bordet, Université libre de Bruxelles
Anderlecht, Belgium
Review Editor
Pharmacology of Anti-Cancer Drugs
Department of Pharmaceutical Sciences, School of Medicine and Surgery, University of Padua
Padua, Italy
Review Editor
Pharmacology of Anti-Cancer Drugs
Italian Institute of Technology (IIT)
Genova, Italy
Review Editor
Pharmacology of Anti-Cancer Drugs
Scientific Institute of Romagna for the Study and Treatment of Tumors (IRCCS)
Meldola, Italy
Review Editor
Pharmacology of Anti-Cancer Drugs
University Hospital of Parma
Parma, Italy
Review Editor
Pharmacology of Anti-Cancer Drugs
Pfizer (United States)
New York, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
Oak Ridge Institute for Science and Education (ORISE)
Oak Ridge, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
Shenyang Pharmaceutical University
Shenyang, China
Review Editor
Pharmacology of Anti-Cancer Drugs
Fudan University
Shanghai, China
Review Editor
Pharmacology of Anti-Cancer Drugs
University Hospital of Padua
Padua, Italy
Review Editor
Pharmacology of Anti-Cancer Drugs
University of Minnesota Duluth
Duluth, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
University of New South Wales
Kensington, Australia
Review Editor
Pharmacology of Anti-Cancer Drugs
Federal University of Ceara
Fortaleza, Brazil
Review Editor
Pharmacology of Anti-Cancer Drugs
The University of Sydney
Darlington, Australia
Review Editor
Pharmacology of Anti-Cancer Drugs
Institut National de la Santé et de la Recherche Médicale (INSERM)
Paris, France
Review Editor
Pharmacology of Anti-Cancer Drugs